Sodium butyrate can inhibit the progression of NAFLD by increasing histone acetylation and enhancing the sensitivity to glucagon-like peptide-1 (Zhou et al., 2018). The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.